Health Care & Life Sciences » Pharmaceuticals | AFC-HD AMS Life Science Co. Ltd.

AFC-HD AMS Life Science Co. Ltd. | Income Statement

Fiscal year is September-August. All values JPY Millions.
2013
2014
2015
2016
2017
Sales/Revenue
14,366
13,728
14,415
14,631
15,142
Cost of Goods Sold (COGS) incl. D&A
9,949
9,617
10,163
10,242
10,535
Gross Income
4,417
4,111
4,253
4,389
4,607
SG&A Expense
3,515
3,546
3,301
3,498
3,538
EBIT
902
565
951
891
1,069
Unusual Expense
65
11
35
28
331
Non Operating Income/Expense
136
51
64
29
35
Interest Expense
127
112
95
79
65
Pretax Income
977
494
956
755
637
Income Tax
404
211
356
269
171
Consolidated Net Income
572
283
600
486
466
Net Income
572
283
606
490
466
Net Income After Extraordinaries
572
283
606
490
466
Net Income Available to Common
572
283
606
490
466
EPS (Basic)
48.14
23.82
50.64
40.47
38.48
Basic Shares Outstanding
12
12
12
12
12
EPS (Diluted)
48.14
23.48
50.00
40.34
38.48
Diluted Shares Outstanding
12
12
12
12
12
EBITDA
1,500
1,073
1,391
1,288
1,454
Non-Operating Interest Income
-
-
-
-
1
Minority Interest Expense
-
-
5
4
-

About AFC-HD AMS Life Science Co.

View Profile
Address
3-6-36 Toyoda
Shizuoka Shizuoka 422
Japan
Employees -
Website http://www.ams-life.com
Updated 09/14/2018
AFC-HD AMS Life Science Co., Ltd. engages in the manufacture of health food and cosmetics. It operates through the Health Care Business and Pharmaceuticals Business segments. The Health Care Business segment includes the manufacture and sale of health food and cosmetics.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.